Plasticell

39 articles about Plasticell

• Plasticell receives EU funding as part of €3.7 million consortium to advance neurodegenerative disease research

  10/31/2018

  Plasticell Ltd, a developer of stem cell technologies and regenerative medicines, has announced that the Advanced Stem Cell Training Network (ASCTN), a European research consortium in which the company is a partner organisation, has successfully bid for over €3,700,000 in funding from the European Union

• Plasticell wins military contract to develop regenerative medicines for the battlefield.

  9/12/2018

  Plasticell Ltd has announced that it  has been contracted by the Ministry of Defence (MoD) in a pilot programme to develop regenerative medicines for the treatment of injuries resulting from combat or terrorism.

• Plasticell leads gene therapy manufacturing consortium with Great Ormond Street Hospital and UCL Institute of Child Health

  6/26/2018

  Plasticell, a developer of stem cell technologies and therapies, has announced it is leading a consortium of pioneering gene therapy groups.

• Plasticell and Anthony Nolan to Partner in Clinical Trials of Ex Vivo Expanded Cord Blood Stem Cells

  12/5/2017

  The project is part of Plasticell's hematopoietic cell therapy portfolio, which includes the expansion of hematopoietic stem cells and the manufacture of various blood cell types from pluripotent cell sources.

• Plasticell And GSK Sign Collaboration Agreement To Produce Hematopoietic Cells From iPSCs.

  10/18/2017

  Plasticell, the biotechnology company specialising in stem cell screening and cell therapy development, has entered into a collaboration with GSK to use its combinatorial stem cell screening technology, CombiCult, to optimise the directed differentiation of induced pluripotent stem cells (iPSCs) to specific blood cell lineages for use by GSK in its therapeutic research.

• Plasticell And King's College London To Collaborate In Trials Of Blood Platelet Substitute

  4/20/2017

• UK’s Innovation Agency Backs Plasticell To Produce Red Blood Cell Substitute From Pluripotent Stem Cells

  4/14/2017

• Plasticell Signs Stem Cell Research Collaborations With Leading Singapore Academic Institutions

  3/29/2017

• Plasticell Increases Flow Of Stem Cell Therapy Pipeline

  2/8/2017

• Published Scientific Data Demonstrates Plasticell's Combicult Technology Platform Expands Stem Cells In Umbilical Cord Blood

  11/23/2016

• Plasticell Completes £1.32 Million Financing To Advance Therapeutic Projects

  11/4/2016

• Plasticell And CellSpring Collaborate To Validate Osteogenic Cell Therapy And 3D Cell Culture Models For High Performance Drug Screening

  9/20/2016

• Plasticell Release: Hematopoietic Stem And Progenitor Cell Gene Therapy: From The Quagmire To Saviour And Beyond

  8/31/2016

• Plasticell And National University Of Ireland Initiate Cancer Stem Cell Collaboration

  8/2/2016

• Plasticell Awarded The Queen’s Award For Enterprise In Innovation 2016

  4/22/2016

• Plasticell And Sphere Fluidics Sign Research Collaboration To Develop Gene Transduction Technology Leading To Safer And More Efficient Gene Therapies

  3/29/2016

• Plasticell And Pierre Fabre Sign A Partnership To Identify Natural Stimulants Of Brown Fat For Treatment And Prevention Of Obesity And Diabetes

  2/23/2016

• Plasticell Appoints Dr Aaron T. T. Chuang As Chief Scientific Officer.

  6/17/2015

• Plasticell Wins Innovate UK Funding For £1.6 Million Cord Blood Stem Cell Manufacturing Project

  2/5/2015

• Published Scientific Data Shows Plasticell’s Massively Parallel Approach Is Set To Transform The Regenerative Medicine Research Landscape

  9/25/2014